Imperial College London
Portrait Picture

Professor Mark Layton

Faculty of Medicine, Department of Immunology and Inflammation

Professor of Practice (Haematology)
 
 
 
//

Contact

 

+44 (0)20 3313 2173m.layton

 
 
//

Assistant

 

Mrs Lisa Pape +44 (0)20 3313 1320

 
//

Location

 

4N3ACommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Kuo:2022,
author = {Kuo, KHM and Layton, DM and Lal, A and Al-Samkari, H and Bhatia, J and Kosinski, PA and Tong, B and Lynch, M and Uhlig, K and Vichinsky, EP},
journal = {LANCET},
pages = {493--501},
title = {Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study},
url = {https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000848646000016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb},
volume = {400},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Kuo,KHM
AU  - Layton,DM
AU  - Lal,A
AU  - Al-Samkari,H
AU  - Bhatia,J
AU  - Kosinski,PA
AU  - Tong,B
AU  - Lynch,M
AU  - Uhlig,K
AU  - Vichinsky,EP
EP  - 501
PY  - 2022///
SN  - 0140-6736
SP  - 493
TI  - Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in adults with non-transfusion dependent α-thalassaemia or β-thalassaemia: an open-label, multicentre, phase 2 study
T2  - LANCET
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000848646000016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 400
ER  -
Download